Caspase inhibition reduces apoptosis and increases survival of nigral transplants

Nature Medicine

Volumn 5, Issue 1, 1999, Pages 97-100

  Schierle, Gabriele S ^a   Hansson, Oskar ^a   Leist, Marcel ^b   Nicotera, Pierluigi ^b   Widner, Hakan ^a   Brundin, Patrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLTYROSINYLVALYLALANYLASPARTYLCHLOROMETHYLKETONE; CASPASE; ENZYME INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELL TRANSPLANTATION; DOPAMINERGIC NERVE CELL; EMBRYONAL TISSUE; ENZYME INHIBITION; GRAFT SURVIVAL; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; BRAIN TISSUE TRANSPLANTATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; FEMALE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0033008216     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/4785     Document Type: Article

References (24)

1. Lindvall, O. Neural transplantation: a hope for patients with Parkinson's disease. Neuroreport 8, III-X (1997).
2. Olanow, C.W., Kordower, J.H. & Freeman, T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19, 102-109 (1996).
3. Kordower, J.H. et al. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 24, 203-230 (1996).
4. Kordower J.H. et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. 13, 383-393 (1998).
5. Barker, R.A., Dunnett, S.B., Faissner, A. & Fawcett, J.W. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol. 141, 79-93 (1996).
6. Zawada, W.M. et al. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786, 96-103 (1998).
7. Villa, P., Kaufmann, S.H. & Earnshaw, W.C. Caspases and caspase inhibitors. Trends Biochem. Sci. 22, 388-393 (1997).
8. Milligan, C.E. et al. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 15, 385-393 (1995).
9. Leist, M. et al. Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Mol. Med. 3, 750-764 (1997).
10. de Bilbao, F. & Dubois-Dauphin, M. Acute application of an interleukin-1 beta-converting enzyme-specific inhibitor delays axotomy-induced motoneurone death. Neuroreport 25, 3051-3054 (1996).
11. Hara, H. et al. Inhibition of interleukin 1 beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA 94, 2007-2012 (1997).
12. Yakovlev, A.G. et al. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. 17, 7415-7424 (1997).
13. Leist, M., Single, B., Castoldi, A.F., Kuhnle, S. & Nicotera, P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185, 1481-1486 (1997).
14. Mahalik, T.J., Hahn, W.E., Clayton, G.H. & Owens, G.P. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129, 27-36 (1994).
15. Nakao, N., Frodl, E.M., Duan, W.-M., Widner, H. & Brundin, P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. USA 191, 12408-12412 (1994).
16. Green, D. & Kroemer, G. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8, 267-271 (1998).
17. Leist, M. & Nicotera, P. Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239, 183-201 (1998).
18. Nakao, N. et al. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nature Med. 1, 226-231 (1995).
19. Rosenblad, C., Martinez-Serrano, A. & Björklund, A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 75, 979-985 (1996).
20. Mayer, E., Fawcett, J.W. & Dunnett, S.B. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons-II. Effects on nigral transplants in vivo. Neuroscience 56, 389-98 (1993).
21. Karlsson, J., Emgård, M., Rosenblad, C. & Brundin, P. Treatment with the spintrap agent α-phenyl-N-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons. Brain Res. 805, 155-168 (1998).
22. Whiteside, G., Cougnon, N., Hunt, S.P. & Munglani, R. An improved method for detection of apoptosis in tissue sections and cell culture, using the TUNEL technique combined with Hoechst stain. Brain Res. Brain Res. Protoc. 2, 160-164 (1998).
23. Duan, W.-M., Widner, H., Cameron, R.M. & Brundin, P. Quinolinic acid-induced inflammation in the striatum does not impair the survival of neural allografts in the rat. Eur. J. Neurosci. 10, 2595-2606 (1998).
24. West, M.J., Slomianka, L. & Gundersen, H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231, 482-497 (1991).